This latest fund represents a significant expansion of the principal investment business of RMG, building on the team's 25-plus year history in life sciences banking, investment and innovation.  KBI brings unique expertise and capabilities with more than 30 years of investment history to the fund. The RMG managing directors leading the fund will be Ted Moon, Bruce Roberts, and Lisa Wisniewski, Ph.D., joined on the investment committee by Lambert Kuk and Min Shin, Pharm.D. from KBI. In addition, the fund management team is being expanded and now includes Sonia Gulati, Ph.D.as a principal.

"We are deeply grateful to our partners for their commitment to the Global BioAccess Fund and their confidence in our ability to access exciting opportunities through the global network we have developed over many years," said Ted Moon. "As life sciences enters into a new era of historic innovation, we are honored to be supporting talented entrepreneurs and science," commented Bruce Roberts.

The management of the Global BioAccess Fund anticipates that the fund will generate multiple opportunities to build innovative biotech companies that can bring medical advances. "It is our goal that the Fund will be the center of a true ecosystem for growing and supporting global leaders in biotechnology and medical technology," said Jong Pil Kim, CEO of KBI